IBMS Davos Workshops: Bone Biology & Therapeutics
Click here to go to the previous page
Clinical Development of Odanacatib for the Treatment of Osteoporosis - part of a Satellite Symposium sponsored by Merck & Co., Inc.
Program Code:
620
Date:
Wednesday, March 12, 2008